Welcome to the e-CCO Library!

P148: Subclinical inflammatory bowel disease precedes the diagnosis and leads to an increase on healthcare resources utilization: multicentric case-control study in the Basque Country
Year: 2022
Source: ECCO'22
Authors: Rodríguez-Lago, I.(1);Aguirre, U.(2);Ramírez de la Piscina, P.(3);Muñagorri, A.(4);Zapata, E.(5);Higuera, R.(6);Montalvo, I.(7);Iriarte, A.(8);Fernández-Calderón, M.(9);Arreba, P.(10);Carrascosa, J.(11);Cabriada, J.L.(1);Barreiro-de Acosta, M.(12);
Created: Friday, 11 February 2022, 3:52 PM
P148: Timing to surgery in symptomatic Crohn’s disease—patients perception
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Moratal1, M. Marti-Gallostra*1, F. Vallribera1, E. Epín1

Created: Friday, 22 February 2019, 9:41 AM
P148: Work Ability Index (WAI) as a suitable instrument to assess work ability among IBD patients
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Mtir, M.(1)*;Mechergui, N.(2);Kchir, H.(1);Cherif, D.(1);Dabbabi, H.(1);Yacoub, H.(1);Hassine, H.(1);Maamouri, N.(1);
Created: Friday, 14 July 2023, 10:48 AM
P149 Ulcerative colitis patients with high calprotectin levels should undergo endoscopy within 7 days for therapeutic decision
Year: 2020
Source:

ECCO'20 Vienna

Authors:

J.O. Kim1, S.R. Jeon1, H. Park1, H.G. Kim1, B.M. Ko1, S. Park2

Created: Thursday, 30 January 2020, 10:12 AM
P149: Application of revised Pediatric Inflammatory Bowel Disease (PIBD) classes criteria to the Korean PIBD patients
Year: 2021
Source: ECCO'21 Virtual
Authors: Shin, M.(1);Lim, J.G.(1);Kim, M.S.(1);Moon, S.Y.(1);Hahn, J.W.(1);Kim, D.H.(1);Moon, J.S.(1);Ko, J.S.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P149: Intestinal perfusion measurements with contrast-enhanced ultrasound and dynamic contrast-enhanced magnetic resonance imaging enterography: A comparison study
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

R. Wilkens*1, 2, D.A. Peters3, A.H. Nielsen1, V.P. Hovgaard1, H. Glerup1, K. Krogh2

Created: Friday, 22 February 2019, 9:49 AM
P149: Long-term clinical outcome of isolated terminal ileal lesions
Year: 2018
Source: ECCO '18 Vienna
Authors:

Y.S. Kim*, Y.M. Woo, J.Y. Kim, K.H. Ko, J.S. Moon

Created: Thursday, 21 February 2019, 9:14 AM
P149: Novel capillary blood point-of-care test for adalimumab and infliximab trough levels: Effects of abnormal blood conditions on the test result
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Brosi, L.(1)*;Reinhard, C.(2);Anchling , L.(2);Afonso, J.(1);Schuster, T.(1);Gerhold, C.B.(1);Ricken, B.(1);
Created: Friday, 14 July 2023, 10:48 AM
P149: Prioritising colonoscopy by faecal immunochemical test result does not delay the diagnosis of inflammatory bowel disease
Year: 2022
Source: ECCO'22
Authors: White, K.(1);Makin, A.(1);
Created: Friday, 11 February 2022, 3:52 PM
P149: Searching for bile acid malabsorption using serum fibroblast growth factor 19 (FGF19) and faecal bile acids in patients with inflammatory bowel diseases, microscopic colitis and irritable bowel syndrome
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

I. Lyutakov*1, R. Nakov1, V. Nakov1, B. Vladimirov1, A. Dimov2, B. Asenova3, M. Chetirska3, R. Vatcheva-Dobrevska3, P. Penchev1

Created: Friday, 22 February 2019, 9:41 AM
P149: Urban life is an independent risk factor for psychological symptoms of the Chinese patients with Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

He H.*1, Zhi M.2, Zhang M.1, Zhang Y.1, Hu J.3, Tang J.1, Su M.1, Gao X.1, Hu P.1

Created: Wednesday, 20 February 2019, 10:36 AM
P150 Risk of hepatitis flare in patients with previous hepatitis B virus exposure amongst inflammatory bowel disease patients: results from a territory-wide Hong Kong IBD Registry study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

J.W.Y. Mak, T.C.F. Yip, H.M. Lam, T.Y. Cheng, S.H. Wong, F.K.L. Chan, S.C. Ng, V.W.S. Wong, G.L.H. Wong

Created: Thursday, 30 January 2020, 10:12 AM
P150: High adherence to surveillance guidelines in IBD results in low CRC and dysplasia rates, while rates of dysplasia and cancer are low before the suggested start of surveillance. Results from a tertiary IBD centre
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

K. Singh1, A. Al Khoury2, Z. Kurti3, L. Gonczi*3, J. Reinglas2, C. Verdon2, R. Kohen2, T. Bessissow2, W. Afif2, G. Wild2, E. Seidman2, A. Bitton2, P. Lakatos2

Created: Friday, 22 February 2019, 9:41 AM
P150: Histologic features predicting prognosis and their relationship with endoscopic findings in Ulcerative Colitis patients with mucosal healing
Year: 2021
Source: ECCO'21 Virtual
Authors: Shin, S.(1);Choi, C.W.(1);Moon, J.M.(1);Kim, H.S.(2);Choi, C.H.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P150: Identification of features associated with poor outcomes in pediatric patients with ulcerative proctitis: A Multicentre Study From the Paediatric IBD Porto Group of ESPGHAN
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Tal-Shifman, N.(1,2)*;Tzivinikos, C.(3);Gasparetto, M.(4);Serban, D.E.(5); Zifman, E.(6); Hojsak, I.(7); Ledder, O.(8); Yerushalmy Feler, A.(9); Rolandsdotter, H.(10); Aloi, M.(11);Bramuzzo, M.(12); Buderus, S.(13);Lionetti, P.(14);Norsa, L.(15); Norden, C.(16);Urlep, D.(17); Romano, C.(18);Shaoul, R.(19);Martinez-Vinson, C.(20);Karoliny, A.(21);Veereman, G.(22); Kang, B.(23);Vlčková, E.(24); Alvisi, P.(25);Kori, M.(26);Tavares, M.(27);Weiss, B.(28);Hussey, S.(29);Essen Qamhawi, M.(30);Palomino Pérez, L.M.(31);Henderson, P.(32); Parmar, R.(33); Miele, E.(34);Firas Rinawi, F.(35);Lonzano-Ruf, A.(36); Zamvar, V.(37); Kolho, K.L.(38);Shouval, D.(1,2);
Created: Friday, 14 July 2023, 10:48 AM
P150: INCREASED RISK OF IBD FLARE AFTER SARS-CoV-2 INFECTION. WHO’S THE MORE GUILTY: VIRAL INFECTION OR THERAPY WITHDRAWAL?
Year: 2022
Source: ECCO'22
Authors: Bezzio, C.(1);Guarino, A.D.(1);Fiorino, G.(2);Armuzzi, A.(3);Ribaldone, D.G.(4);Furfaro, F.(5);Pugliese, D.(3);Vernero, M.(6);Variola, A.(7);Gerardi, V.(8);Scucchi, L.(9);Viganò, C.(10);Caprioli, F.A.(11);Roselli, J.(12);Coppini, F.(13);Ardizzone, S.(14);Onali, S.(15);Zingone, F.(16);Daperno, M.(17);Cortellezzi, C.(18);Carparelli, S.(19);Soriano, A.(20);Manes, G.(1);Saibeni, S.(1);
Created: Friday, 11 February 2022, 3:52 PM
P150: Low diagnostic accuracy of faecal calprotectin to predict mucosal inflammation in Crohn’s disease patients with active perianal fistulas
Year: 2018
Source: ECCO '18 Vienna
Authors:

T. Stevens1*, G. D'Haens1, C. Buskens2, W. Bemelman2, K. Gecse1

Created: Thursday, 21 February 2019, 9:14 AM
P150: Pregnancy complications and outcomes in patients with inflammatory bowel disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Yokoyama Y.*1, Tanaka H.2, Nishio A.1, Sato T.1, Kawai M.1, Kamikozuru K.1, Kita Y.1, Miyazaki T.1, Hida N.1, Hori K.1, Nakamura S.1

Created: Wednesday, 20 February 2019, 10:36 AM
P150: Zinc deficiency is associated with increased disease-related morbidity in Crohn’s disease patients
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

S. S. Siva*1, D. T. Rubin1, G. Gulotta1, K. Wroblewski2, J. Pekow1

Created: Friday, 22 February 2019, 9:49 AM
P151 Can two different faecal calprotectin assays be used interchangeably in inflammatory bowel disease treatment?
Year: 2020
Source:

ECCO'20 Vienna

Authors:

E. Van Wassenaer MD1, K. Diederen1, A. Kindermann1, E.M.M. van Leeuwen2, G.R. D’Haens3, M.A. Benninga1, B.G.P. Koot1

Created: Thursday, 30 January 2020, 10:12 AM